Q&A: How Is Risankizumab’s FDA Approval Changing the Psoriatic Disease Landscape?
Q&A: How Is Risankizumab’s FDA Approval Changing the Psoriatic Disease Landscape? HCP Live
Finance, IT & News
Q&A: How Is Risankizumab’s FDA Approval Changing the Psoriatic Disease Landscape? HCP Live
Takeda wins approval for first Dengue vaccine in India medwatch.com
FDA clears combined patient warming, securement device for robotic surgery Medical Economics
How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD HCP Live
FDA Approves Bioequivalent Olaparib in Across Previously Approved Cancer Indications OncLive